These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 18220696

  • 1. Efficacy of pentoxifylline in the management of microalbuminuria in patients with diabetes.
    Rodríguez-Morán M, Guerrero-Romero F.
    Curr Diabetes Rev; 2008 Feb; 4(1):55-62. PubMed ID: 18220696
    [Abstract] [Full Text] [Related]

  • 2. Pentoxifylline is as effective as captopril in the reduction of microalbuminuria in non-hypertensive type 2 diabetic patients--a randomized, equivalent trial.
    Rodríguez-Morán M, Guerrero-Romero F.
    Clin Nephrol; 2005 Aug; 64(2):91-7. PubMed ID: 16114784
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative effects of indapamide and captopril on blood pressure and albumin excretion rate in diabetic microalbuminuria.
    Donnelly R, Molyneaux LM, Willey KA, Yue DK.
    Am J Cardiol; 1996 Feb 22; 77(6):26B-30B. PubMed ID: 8848991
    [Abstract] [Full Text] [Related]

  • 6. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R, Brocco E.
    Exp Clin Endocrinol Diabetes; 1997 Feb 22; 105 Suppl 2():1-7. PubMed ID: 9288531
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pentoxifylline for diabetic kidney disease.
    Shan D, Wu HM, Yuan QY, Li J, Zhou RL, Liu GJ.
    Cochrane Database Syst Rev; 2012 Feb 15; (2):CD006800. PubMed ID: 22336824
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.
    McCormick BB, Sydor A, Akbari A, Fergusson D, Doucette S, Knoll G.
    Am J Kidney Dis; 2008 Sep 15; 52(3):454-63. PubMed ID: 18433957
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points.
    Parving HH, Andersen S, Jacobsen P, Christensen PK, Rossing K, Hovind P, Rossing P, Tarnow L.
    Semin Nephrol; 2004 Mar 15; 24(2):147-57. PubMed ID: 15017527
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients.
    Halimi JM.
    Diabetes Metab; 2012 Oct 15; 38(4):291-7. PubMed ID: 22622176
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effects of angiotensin-converting enzyme inhibitors on the clinical and biochemical parameters in diabetic nephropathy.
    Gültekin F, Erdoğan GH, Ozersoy U, Alagözlü H.
    Ren Fail; 1993 Oct 15; 15(5):615-22. PubMed ID: 8290708
    [Abstract] [Full Text] [Related]

  • 17. Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy.
    Roozbeh J, Banihashemi MA, Ghezlou M, Afshariani R, Salari S, Moini M, Sagheb MM.
    Ren Fail; 2010 Jan 15; 32(2):172-8. PubMed ID: 20199178
    [Abstract] [Full Text] [Related]

  • 18. Telmisartan in incipient and overt diabetic renal disease.
    Schmieder RE, Bakris G, Weir MR.
    J Nephrol; 2011 Jan 15; 24(3):263-73. PubMed ID: 21374585
    [Abstract] [Full Text] [Related]

  • 19. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.
    McKenna K, Thompson C.
    Scott Med J; 1997 Aug 15; 42(4):99-104. PubMed ID: 9507584
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.